Inogen | INGN - الربح قبل الضريبة

سعر السهم
7.12
التغيير اليومي
0.07 0.99%
شهريا
4.71%
سنويا
-0.70%
Q2 التوقعات
6.83




الربح قبل الضريبة تغيير تاريخ
Abbott USD 2.39B 27M 2026-03
Accuray USD 3.23M 6.56M 2024-12
AngioDynamics USD -6.4M 5.03M 2025-09
Artivion USD 11.4M 7.84M 2025-12
AtriCure USD 394K 1.97M 2026-03
Baxter International USD -756M 877M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
Chart Industries USD 43.5M 226.2M 2025-12
Cooper Companies USD 116.8M 137.4M 2025-09
Dexcom USD 340.7M 40.7M 2025-12
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Globus Medical USD 143.99M 44.18M 2025-09
Inogen USD -6.06M 467K 2024-09
Insulet USD 140.2M 17.4M 2025-12
Masimo USD 74.9M 19.5M 2025-09
Medtronic USD 2.1B 224M 2025-09
Orthofix International USD -2.19M 20.07M 2025-12
Philips EUR 466M 191M 2025-12
ResMed USD 496.15M 13.77M 2025-12
Steris USD 324.4M 92.5M 2025-09
Stryker USD 1.7B 676M 2025-12
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
X T L Biopharmaceuticals USD -385K 168K 2024-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12